Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stanulis

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Neuropsychologia|September 1, 1993
Ocular dysfunction during the amytal suppression testJ DeToledo, D B Smith, R Stanulis
Clinical Pharmacology and Therapeutics|April 19, 2017
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical TrialsD M Longo, G T Generaux, B A Howell, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Neuropsychologia|September 1, 1993
Ocular dysfunction during the amytal suppression testJ DeToledo, D B Smith, R Stanulis
Clinical Pharmacology and Therapeutics|April 19, 2017
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical TrialsD M Longo, G T Generaux, B A Howell, et al.
Pageof 1